About Us
The EpiMethyl team includes biomedical scientists, molecular biologists, computational scientists, biostatisticians and data engineers who are experts at merging biology with data science.
EpiMethyl Analytics: A powerful platform to revolutionize human health
Your body is an information system. Epigenetic processes control how you develop and how your system responds to environment. Stress, pollution, poor nutrition, genetic disorders, and aging can all cause adjustments to your epigenetic state. These changes can be detected.
EpiMethyl Analytics uses sensitive and proprietary methods for detecting and decoding these changes, allowing you to understand your health better and to detect disease occurrence earlier. There is power in this information, for more accurate diagnosis, optimal treatment timing, and drug target design. We aim to make a difference in this world by making you a more informed patient, parent, doctor, scientist.
Our Leadership
Robert Dieterle
CHIEF EXECUTIVE OFFICER
Robert Dieterle is an experienced entrepreneur and executive with a long record of the successful creation and management of technology and clinical diagnostic businesses. He has deep experience in laboratory diagnostics, in particular genomic diagnostics, as well as information technology. He was President of Correlagen, General Manager of the Cerner Corporation, CEO of the Cerner Consortium in the UK, COO of Careinsite, and President of THINC in NYC. He spent the last several years working with HHS, CMS, and ONC to develop national standards to protect and exchange healthcare information to improve the health and wellbeing of patients. His relationships with both provider and payer organizations have been developed over multiple decades and will strongly contribute to the success of the company’s mission. Robert received degrees in Chemistry and Bioengineering from the University of Michigan.
Sally Mackenzie, phd
Corporate Scientific Officer
Dr. Sally Mackenzie is a molecular biologist who served as the Lloyd and Dottie Huck Chair for Plant Functional Genomics in the Department of Biology at Penn State University. She also served as the Ralph and Alice Raikes Chair in Plant Science and Founding Director of the Center for Plant Science Innovation at the University of Nebraska, and as Professor of Plant Genetics at Purdue University. She holds a Ph.D. in Plant Molecular Genetics from the University of Florida, Gainesville and a B.S. in Plant Biology from UC Davis.
Robersy Sanchez, PhD
Corporate Technology Officer
Dr. Robersy Sanchez is the creator of EpiMethyl Analytics Technology in collaboration with Dr. Sally Mackenzie. He has been working in the field of Mathematical and Computational Biology for almost 20 years. He holds a PhD in Genetics from Havana University (UH), a Master’s degree in Applied Mathematics (UCLV) and a Bachelor of Science degree in Biochemistry (UH). His work in epigenomics research is founded on the mathematical-computational modeling of DNA methylation processes and follows a multifaceted approach deriving from the fields of Biophysics/Biochemistry (thermodynamics), Information Theory, Genomics and Machine learning.
Our Board of Directors
Robert Dieterle
Sally Mackenzie
